SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,478,710 | +8.7% | 28,296 | +0.0% | 0.01% | +25.0% |
| Q2 2023 | $3,199,203 | +102.7% | 28,284 | +145.7% | 0.00% | +100.0% |
| Q1 2023 | $1,578,136 | +574.4% | 11,510 | +260.5% | 0.00% | – |
| Q1 2021 | $234,000 | -57.0% | 3,193 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $544,000 | +18.8% | 3,193 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $458,000 | -55.2% | 3,193 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $1,022,000 | +226.5% | 6,386 | +100.0% | 0.00% | 0.0% |
| Q1 2020 | $313,000 | -24.6% | 3,193 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $415,000 | +3.8% | 3,193 | -40.2% | 0.00% | 0.0% |
| Q3 2019 | $400,000 | – | 5,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |